Combination therapy of Avonex and doxycycline in patients with multiple sclerosis
| Author | Naser Sharafaddinzadeh | en |
| Author | Nastaran Majdinasab | en |
| Author | Majid Keyhanifard | en |
| Author | Armaghan Moravej-Aleali | en |
| Issued Date | 2011-01-31 | en |
| Abstract | Background : Multiple sclerosis is an inflammatory, chronic demyelinating disease of the central nervous system (CNS) with unknown etiology. Multiple sclerosis causes disability in young people . An Immunomodulatory drug like Avonex (IFN β1a) is used to prevent relapses or disease progression . The aim of this study is to evaluate efficacy of combination therapy (Avonex and doxycycline) with standard therapy (Avonex) in remitting-relapsing multiple sclerosis (RRMS). | en |
| DOI | https://doi.org/ | en |
| Keyword | Multiple sclerosis | en |
| Keyword | avonex | en |
| Keyword | doxycycline | en |
| Publisher | Brieflands | en |
| Title | Combination therapy of Avonex and doxycycline in patients with multiple sclerosis | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ZJRMS-v12n5p65-en.pdf
- Size:
- 186.88 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF